Keyphrases
Chemotherapy
83%
HPV16
83%
Low Physical Activity
83%
Adults at Risk
83%
Internal Validation
83%
Older Adults
83%
Cervical Cancer
83%
Prediction Model
83%
T Cell Response
83%
Hospitalization
83%
Physical Activity Level
83%
Vaccination
83%
Long Peptides
83%
Prospective Cohort Study
83%
Development Validation
83%
High Risk
50%
Activity Measure
50%
Post-acute Care
50%
Short Physical Performance Battery
50%
Confidence Interval
33%
Walking Aids
33%
Synthetic Peptides
27%
Vaccine Response
20%
Discriminative Ability
16%
Model Performance
16%
Clinical Impact
16%
Accelerometer
16%
Internal Medicine
16%
Bootstrap
16%
Potential Predictors
16%
INIS
patients
100%
performance
83%
prediction
83%
correlations
83%
activity levels
83%
adults
83%
peptides
83%
validation
83%
cancer
83%
chemotherapy
83%
risks
83%
probability
66%
vaccines
52%
calibration
50%
auc
33%
sex
33%
doses
31%
antigens
20%
spending
16%
internal medicine
16%
accelerometers
16%
regression analysis
16%
inclusions
16%
increasing
16%
curves
16%
medical centers
16%
universities
16%
interventions
16%
immunity
10%
mice
10%
Medicine and Dentistry
Human Papillomavirus Type 16
83%
Physical Activity Level
83%
Prospective Cohort Study
83%
Cervical Cancer
83%
T-Cell Response
83%
Chemotherapy
83%
Physical Performance
50%
Subacute Care
50%
Walking Aid
33%
Internal Medicine
16%
Activities of Daily Living
16%
Clinician
16%
Logistic Regression Analysis
16%
Disease
16%
Accelerometer
16%
Health Outcomes
16%
Bootstrapping
16%
Peptide Vaccine
10%
Single Drug Dose
10%
Interferon
10%
Clinical Trial
10%
Myeloid Cell
10%
Immunosuppressive Drug
10%
Chemoimmunotherapy
10%
Immune Response
10%
Immunocompetence
10%
Protein E7
10%
Protein E6
10%
Overall Survival
10%
